171 results on '"Furci L"'
Search Results
52. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
- Author
-
Brezzi, B, Del Prete, D, Lupo, A, Magistroni, R, Gomez Lira, M, Bernich, P, Anglani, F, Mezzabotta, F, Turco, A, Furci, L, Ceol, M, Antonucci, F, Abaterusso, C, Bonfante, L, D'Angelo, A, Albertazzi, A, Gambaro, Giovanni, Gambaro, Giovanni (ORCID:0000-0001-5733-2370), Brezzi, B, Del Prete, D, Lupo, A, Magistroni, R, Gomez Lira, M, Bernich, P, Anglani, F, Mezzabotta, F, Turco, A, Furci, L, Ceol, M, Antonucci, F, Abaterusso, C, Bonfante, L, D'Angelo, A, Albertazzi, A, Gambaro, Giovanni, and Gambaro, Giovanni (ORCID:0000-0001-5733-2370)
- Abstract
BACKGROUND: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and is characterized by extremely variable clinical and morphological features and outcome. TGF-beta1 has a key role in fibrogenesis and the progression of renal damage. Its production is under genetic control. METHODS: We recruited 105 Italian biopsy-proven IgAN patients for genotyping for the TGF-beta1 C-509T, T869C (COD 10) and G915C (COD 25) polymorphisms; 200 healthy blood donors were used as normal controls. Glomerular and interstitial mRNA levels of TGF-beta1 were assessed by real-time PCR in 34 patients to seek relationships with clinical, renal histopathological features and outcome. RESULTS: The genotype distributions in the IgAN population were not statistically different from the controls. The COD 10 TT genotype was associated with more severe histological damage as assessed by Lee's classification (CC 50%, CT 39.6% and TT 17.2% were graded as mild; CC 35.7%, CT 43.7% and TT 44.8% as moderate, and CC 14.3%, CT 16.7% and TT 37.9% as severe [p=0.0049]) and with severe interstitial infiltrates (CC 10.4%, CT 35.2% and TT 54.2% [p=0.03]). A higher interstitial immunodeposition was observed for TGF-beta1, collagen IV and alpha-SMA in patients with the COD 10 T allele (p=0.045, p=0.049, p=0.032, respectively). The T allele was associated with significantly higher TGF-beta1 mRNA levels in the interstitium (TT+CT vs. CC: 0.52 +/- 0.16 vs. 0.18 +/- 0.10 copies/mL, respectively; p=0.000). The T allele was also associated with higher mRNA levels in glomeruli, though the difference was not statistically significant. Finally, the T allele was significantly associated with a worse prognosis, the end points being reached by 40% of TT+CT and 32% of CC patients (p=0.009). CONCLUSIONS: In primary IgA nephropathy, the T allele of the TGF-beta1 COD 10 C/T polymorphism seems to be associated with more severe histological lesions, higher renal TGF-beta1 mRNA levels and a worse prognosis.
- Published
- 2009
53. Acute renal failure of medical type in an elderly population
- Author
-
Baraldi, A, Ballestri, M, Rapana, R, Lucchi, L, Borella, Paola, Leonelli, M, Furci, L, and Lusvarghi, E.
- Subjects
elderly age ,Acute renal failure (ARF) ,serum creatinine ,risk factors - Published
- 1998
54. A validated model of disease progression in IgA nephropathy
- Author
-
Magistroni, R, Furci, L, Leonelli, M, Masellis, M, Ligabue, G, Lucchi, L, Lupo, A, Brezzi, B, Gambaro, Giovanni, Manganelli, L, Pedrazzi, G, Ricardi, M, Bormioli, L, Albertazzi, A., Gambaro, Giovanni (ORCID:0000-0001-5733-2370), Magistroni, R, Furci, L, Leonelli, M, Masellis, M, Ligabue, G, Lucchi, L, Lupo, A, Brezzi, B, Gambaro, Giovanni, Manganelli, L, Pedrazzi, G, Ricardi, M, Bormioli, L, Albertazzi, A., and Gambaro, Giovanni (ORCID:0000-0001-5733-2370)
- Abstract
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.
- Published
- 2006
55. Rapporto sul Registro Nazionale delle Biopsie Renali (1987-1993)
- Author
-
Cazzato, F., Della Volpe, M., Pallotta, G., Bibiano, L., Bizzarri, D., Iannaccone, S., Messina, G., Caramello, E., Pasquali, S., Strada, A., Pani, A., Bonadonna, A., Dugo, M., Spanti, D., Palmieri, Pf, Vallino, F., Quarenchi, M., Bufano, G., Storari, A., Passione, A., Garibotto, G., Patruno, P., Pozzi, C., Farina, M., Tarachini, R., Lupi, Gp, Ponticelli, C., Furci, L., Grasso, C., Sorice, P., Cusaro, C., Bono, M., Cambi, V., Buoncristiani, U., Cioni, L., Tesio, F., Fusaroli, M., Zoccali, C., Rustichelli, R., Cagnoli, L., Cinotti, Ga, Stallone, C., Pedrini, L., Scatizzi, A., Roccatello, Dario, Piccoli, G., Manganaro, M., Rovati, C., Borghi, M., Maschio, G., and Ancarani, A.
- Published
- 1996
56. Il Registro Italiano del Rene Policistico Autosomico Dominante
- Author
-
Carrera, P., primary, Palmieri, L., additional, Caruso, F., additional, Lodi, D., additional, Rigo, F., additional, Furci, L., additional, Granito, M., additional, Damiano, F., additional, Iatrino, R., additional, Boletta, A., additional, Ferrari, M., additional, Aguiari, G., additional, and Magistroni, R., additional
- Published
- 2010
- Full Text
- View/download PDF
57. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype
- Author
-
Cd, Funk, Furci L, Ga, Fitzgerald, Ryszard Grygorczyk, Rochette C, Ma, Bayne, Abramovitz M, Adam M, and Km, Metters
- Subjects
DNA, Complementary ,Base Sequence ,Sequence Homology, Amino Acid ,Xenopus ,Molecular Sequence Data ,Receptors, Thromboxane ,Dinoprostone ,Tumor Cells, Cultured ,Animals ,Humans ,Receptors, Prostaglandin E ,Amino Acid Sequence ,Cloning, Molecular ,Cells, Cultured - Abstract
A functional cDNA clone coding for the human prostaglandin E receptor EP1 subtype has been isolated from a human erythroleukemia cell cDNA library probed by low-stringency hybridization using a polymerase chain reaction fragment of the human thromboxane receptor. The human EP1 receptor is comprised of 402 amino acids with a predicted molecular mass of 41,858 and has the topography common to all G-protein-coupled receptors with seven predicted transmembrane spanning domains. Prostaglandin (PG) E2 challenge of Xenopus oocytes injected with EP1 cDNA resulted in an increase in intracellular Ca2+. In addition, the rank order of potency for prostaglandins in competition for [3H]PGE2 specific binding to membranes prepared from EP1 cDNA transfected COS cells was PGE2PGE1PGF2 alphaPGD2. Furthermore, the EP1 receptor-selective antagonists AH 6809 and SC19220 were more potent than the EP2 receptor-selective agonist butaprost in these competition binding assays. In summary, therefore, we have cloned the human EP1 receptor subtype which is functionally coupled to an increase in intracellular Ca2+.
- Published
- 1993
58. The MEST score provides earlier risk prediction in lgA nephropathy
- Author
-
Barbour, Sean J., Espino-Hernandez, Gabriela, Reich, Heather N., Coppo, Rosanna, Roberts, Ian S.D., Feehally, John, Herzenberg, Andrew M., Cattran, Daniel C., Bavbek, N., Cook, T., Troyanov, S., Alpers, C., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J., D’Agati, V., D’Amico, G., Emancipator, S., Emmal, F., Ferrario, F., Fervenza, F., Florquin, S., Fogo, A., Geddes, C., Groene, H., Haas, M., Hill, P., Hogg, R., Hsu, S., Hunley, T., Hladunewich, M., Jennette, C., Joh, K., Julian, B., Kawamura, T., Lai, F., Leung, C., Li, L., Li, P., Liu, Z., Massat, A., Mackinnon, B., Mezzano, S., Schena, F., Tomino, Y., Walker, P., Wang, H., Weening, J., Yoshikawa, N., Zhang, H., Coppo, R., Troyanov, S., Cattran, D.C., Cook, H.T., Feehally, J., Roberts, I., Tesar, V., Maixnerova, D., Lundberg, S., Gesualdo, L., Emma, F., Fuiano, L., Beltrame, G., Rollino, C., RC, Amore, A., Camilla, R., Peruzzi, L., Praga, M., Feriozzi, S., Polci, R., Segoloni, G., Colla, L., Pani, A., Angioi, A., Piras, L., JF, Cancarini, G., Ravera, S., Durlik, M., Moggia, E., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Caliskan, Y., Sever, M., Kilicaslan, I., Locatelli, F., Del Vecchio, L., Wetzels, J.F.M., Peters, H., Berg, U., Carvalho, F., da Costa Ferreira, A.C., Maggio, M., Wiecek, A., Ots-Rosenberg, M., Magistroni, R., Topaloglu, R., Bilginer, Y., D’Amico, M., Stangou, M., Giacchino, F., Goumenos, D., Kalliakmani, P., Gerolymos, M., Galesic, K., Geddes, C., Siamopoulos, K., Balafa, O., Galliani, M., Stratta, P., Quaglia, M., Bergia, R., Cravero, R., Salvadori, M., Cirami, L., Fellstrom, B., Kloster Smerud, H., Ferrario, F., Stellato, T., Egido, J., Martin, C., Floege, J., Eitner, F., Lupo, A., Bernich, P., Menè, P., Morosetti, M., van Kooten, C., Rabelink, T., Reinders, M.E.J., Boria Grinyo, J.M., Cusinato, S., Benozzi, L., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Martina, G., Messuerotti, A., Dal Canton, A., Esposito, C., Migotto, C., Triolo, G., Mariano, F., Pozzi, C., Boero, R., Bellur, S., Mazzucco, G., Giannakakis, C., Honsova, E., Sundelin, B., Di Palma, A.M., Ferrario, F., Gutiérrez, E., Asunis, A.M., Barratt, J., Tardanico, R., Perkowska-Ptasinska, A., Arce Terroba, J., Fortunato, M., Pantzaki, A., Ozluk, Y., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., Galesic Ljubanovic, D., Gakiopoulou, H., Bertoni, E., Cannata Ortiz, P., Karkoszka, H., Groene, H.J., Stoppacciaro, A., Bajema, I., Bruijn, J., Fulladosa Oliveras, X., Maldyk, J., and Ioachim, E.
- Abstract
The Oxford Classification of IgA nephropathy (IgAN) includes the following four histologic components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and interstitial fibrosis/tubular atrophy (T). These combine to form the MEST score and are independently associated with renal outcome. Current prediction and risk stratification in IgAN requires clinical data over 2 years of follow-up. Using modern prediction tools, we examined whether combining MEST with cross-sectional clinical data at biopsy provides earlier risk prediction in IgAN than current best methods that use 2 years of follow-up data. We used a cohort of 901 adults with IgAN from the Oxford derivation and North American validation studies and the VALIGA study followed for a median of 5.6 years to analyze the primary outcome (50% decrease in eGFR or ESRD) using Cox regression models. Covariates of clinical data at biopsy (eGFR, proteinuria, MAP) with or without MEST, and then 2-year clinical data alone (2-year average of proteinuria/MAP, eGFR at biopsy) were considered. There was significant improvement in prediction by adding MEST to clinical data at biopsy. The combination predicted the outcome as well as the 2-year clinical data alone, with comparable calibration curves. This effect did not change in subgroups treated or not with RAS blockade or immunosuppression. Thus, combining the MEST score with cross-sectional clinical data at biopsy provides earlier risk prediction in IgAN than our current best methods.
- Published
- 2016
- Full Text
- View/download PDF
59. Importance of Serological Determination of Hip in Nephrology
- Author
-
Furci, L., Di Felice, A., Furci, L., and Di Felice, A.
- Abstract
No abstract, non disponibile
- Published
- 1994
60. CD8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review
- Author
-
Furci, L., primary, Polo, S., additional, and Lusso, P., additional
- Published
- 1998
- Full Text
- View/download PDF
61. β1 and β3 integrin upregulation in rapidly progressive glomerulonephritis
- Author
-
Baraldi, A., primary, Zambruno, G., additional, Furci, L., additional, Ballestri, M., additional, Tombesi, A., additional, Ottani, D., additional, Lucchi, L., additional, and Lusvarghi, E., additional
- Published
- 1995
- Full Text
- View/download PDF
62. “Importanza Della Determinazione Sierologica Degli Anca in Nefrologia”
- Author
-
Furci, L., primary and Di Felice, A., additional
- Published
- 1994
- Full Text
- View/download PDF
63. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
- Author
-
Funk, C D, primary, Furci, L, additional, FitzGerald, G A, additional, Grygorczyk, R, additional, Rochette, C, additional, Bayne, M A, additional, Abramovitz, M, additional, Adam, M, additional, and Metters, K M, additional
- Published
- 1993
- Full Text
- View/download PDF
64. RENE POLICISTICO AUTOSOMICO DOMINANTE: DAI GENI AL CILIO.
- Author
-
Magistroni, R., Furci, L., and Albertazzi, A.
- Published
- 2008
65. Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase.
- Author
-
Funk, C D, primary, Furci, L, additional, and FitzGerald, G A, additional
- Published
- 1990
- Full Text
- View/download PDF
66. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
- Author
-
Furci, L, Fitzgerald, D J, and Fitzgerald, G A
- Abstract
Studies of the hierarchies of agonist and antagonist affinity for the prostaglandin (PG)H2/thromboxane (Tx)A2 receptor have been performed to establish whether distinct receptor subtypes exist in platelets and vascular smooth muscle cells (VSMC). They have yielded conflicting results. The pattern of homologous desensitization of phospholipase C activation and [Ca++i] increase induced by the PGH2/TxA2 agonist U46619 in rat aortic SMC was similar to that previously observed in human platelets: rapid desensitization of both responses followed by a delayed loss of binding sites from the cell membrane. Recently, the pattern of receptor inactivation by the antagonist ligand, GR 32191, has identified two subtypes in platelets. GR 32191 binds reversibly (GRr) to a site that mediates platelet shape change and an increase [Ca++i] and irreversibly (GRirr) to a site linked to phospholipase C activation and aggregation. In contrast to platelets, studies of ligand dissociation only identified GRr sites in rat aortic SMC and GR 32191 failed to inactivate PGH2/TxA2 receptors as detected by the PGH2/TxA2 receptor antagonist, [3H]SQ 29548. Inhibition of U46619-induced contraction of both rat aortic and human saphenous vein was competitive, consistent with the absence of GRirr sites in VSMC. Platelet activating factor, which heterologously desensitizes U46619-evoked phospholipase C activation in platelets, had no such effect in VSMC. The biochemical events attendant to PGH2/TxA2 receptor desensitization are similar in SMC and platelets. However, both the pattern of receptor inactivation by GR 32191 and of heterologous desensitization by PAF, suggest that VSMC lack the receptor subtype that transduces aggregation of platelets.
- Published
- 1991
67. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection
- Author
-
Beretta, A., Furci, L., Burastero, S., Cosma, A., Dinelli, M. E., Lopalco, L., Santis, C. De, Tambussi, G., Carrow, E., and Sabbatani, S.
- Published
- 1996
- Full Text
- View/download PDF
68. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
- Author
-
Funk, C D, Furci, L, Moran, N, and Fitzgerald, G A
- Abstract
Thromboxane A2, a potent platelet agonist and vasoconstrictor, exerts its actions via specific G protein-coupled receptors. cDNAs encoding the full length thromboxane receptor have been isolated from human placenta mRNA by reverse transcriptase-polymerase chain reaction. An expression construct, under control of the cytomegalovirus promoter, was introduced into human embryonic kidney 293 cells. Membranes from transfected cells bound the thromboxane antagonist SQ29,548 and the agonist [15-(1 alpha,2 beta(5z)-3 alpha(1E,3S)-4 alpha)]-7-[3-(3-hydroxy-4-(p- iodophenoxy)-1-butenyl)-7-oxabicyclo[2,2,1]hept-2-yl]-5-heptenoic acid) with high affinities, and significantly more receptors were expressed in these cells, compared with platelet preparations. The putative seventh transmembrane segment is highly related in all cloned members of the eicosanoid receptor family and forms a critical portion of the ligand binding pocket for G protein-coupled receptors. Several point mutations in this segment were generated. Binding of SQ29,548 was virtually abolished in cells transfected with all the variant receptor constructs. However, one receptor variant (TxR-W299L), in which a tryptophan at position 299 was substituted for a leucine residue, allowed a definite discrimination between agonist and antagonist binding sites in competition and saturation binding experiments. An antibody directed toward the third intracellular loop of the thromboxane receptor was able to immunoprecipitate native thromboxane receptor in solubilized membranes from human erythroleukemia cells and transfected cells.
- Published
- 1993
69. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group
- Author
-
Pozzi, C., Pasquali, S., Donini, U., Casanova, S., Banfi, G., Tiraboschi, G., Furci, L., Porri, M. T., Ravelli, M., and Lupo, Antonio
- Subjects
myeloma ,acute renal failure ,prognostic factors - Published
- 1987
70. I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD)
- Author
-
Riccardo Magistroni, Furci, L., Leonelli, M., Ballestri, M., Ligabue, G., Martino, C., Scapoli, C., and Albertazzi, A.
- Subjects
Nefropatia a depositi di IgA ,angiotensina II ,RAS
71. Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection
- Author
-
Malnati, M. S., Giuseppe Tambussi, Clerici, E., Polo, S., Algeri, M., Nardese, V., Furci, L., Lazzarin, A., and Lusso, P.
72. Cyclosporin-induced endothelial cell injury
- Author
-
carlamaria zoja, Furci, L., Ghilardi, F., Zilio, P., Benigni, A., and Remuzzi, G.
- Subjects
Thromboxane A2 ,L-Lactate Dehydrogenase ,Cell Adhesion ,Temperature ,Animals ,Blood Vessels ,Cattle ,Cyclosporins ,Endothelium ,Epoprostenol ,Aorta ,Cells, Cultured ,Chromium Radioisotopes - Abstract
The administration of Cyclosporin-A (CyA) to animals and humans may induce an arteriolar damage. It has also been reported that CyA in some instances may cause an hemolytic uremic-like syndrome. This is a syndrome of vascular damage with thrombotic occlusions of the microcirculation. Endothelial injury is considered the first event in the pathogenetic cascade leading to hemolytic-uremic syndrome. We have used bovine aortic endothelial cells in culture to address the issue of CyA-induced arteriolar damage. Exposure of endothelial cells to different concentrations of CyA induced a time- and dose-dependent cell injury in vitro. The damage induced by CyA was characterized by an early cell detachment from culture substrate followed by cell lysis as documented by the increase in lactate dehydrogenase (LDH) and 51Cr release. Both detachment and lysis were negligible after short-term incubation of 1 microM CyA with endothelial cells. One micromolar CyA only induced lysis if incubations were prolonged above 6 hours. Ten and 50 microM CyA both induced marked endothelial cell detachment and lysis; lysis started 3 hours after incubation of endothelial cells with CyA and was maximal at the end of 24 hours incubation. CyA-induced injury was associated with dose- and time-dependent increase in prostacyclin and thromboxane A2 release by endothelial cells exposed to CyA independently from the concentrations of CyA used. CyA-induced generation of prostacyclin and thromboxane A2 was inhibited when the incubations were performed in the presence of aspirin (500 microM). These studies indicate that CyA exerts a direct cytotoxic effect on endothelial cells and might help in understanding the pathogenesis of CyA-induced vascular damage.
73. Renin-angiotensin system (RAS) DNA polymorphisms and TGF beta 1-mediated fibrogenic pathway gene expression studies in primary IgA nephropathy (Berger's disease)
- Author
-
Turco, A., Patuzzo, C., Brugnara, M., Marcantoni, C., Brezzi, B., Lupo, A., Gambaro, G., Anglani, F., Del Prete, D., Ligabue, G., Furci, L., Riccardo Magistroni, Albertazzi, A., and Maschio, G.
74. Heterogeneity in exposed uninfected individuals
- Author
-
Lopalco, L., Pastori, C., Barassi, C., Furci, L., Burastero, S., Lillo, E., Boeri, E., Soldini, L., Giuseppe Tambussi, Lazzarin, A., Beretta, A., and Siccardi, A. G.
75. A validated model of disease progression in IgA nephropathy
- Author
-
Riccardo Magistroni, Furci, L., Leonelli, M., Masellis, M., Ligabue, G., Lucchi, L., Lupo, A., Brezzi, B., Gambaro, G., Manganelli, L., Pedrazzi, G., Ricardi, M., Bormioli, L., and Albertazzi, A.
- Subjects
Adult ,Male ,Adolescent ,Biopsy ,Glomerulonephritis, IGA ,Prognosis ,Survival Rate ,IgA-N ,retrospectively study ,renal survival ,Italy ,Disease Progression ,Humans ,Settore MED/14 - NEFROLOGIA ,Female ,Immunosuppressive Agents ,Follow-Up Studies ,Retrospective Studies - Abstract
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.This study retrospectively reviewed IgAN cases collected since 1981 to identify clinical and/or histological parameters for disease progression; 310 patients with biopsy proven IgAN, diagnosed from January 1981 to March 2004, were included.We defined a clinical prognostic index (CPI) using multivariate analysis, which incorporated these clinical/ histological parameters. Semiquantitative scores were assigned as follows: 2 points if creatinine (Cr) was1.4 mg/dL, 1 point if proteinuria was1 g/24 hr, 1 point if a patient was affected by hypertension, and 1 point if a patient was older than 30 yrs. Dividing our population into two groups (scores 0-2 = low CPI group; scores 3-5 = high CPI group), we demonstrated a significantly different 10-yr renal survival rate; in the low CPI group, renal survival since time of biopsy at 10 yrs was 91.7%; in the high CPI group the renal survival at 10 yrs was 35%. We validated the CPI in an independent sample from Verona (validation group) and demonstrated similar results for the CPI.The CPI is convenient to use for defining the risk of disease progression.
76. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4+ T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
- Author
-
Furci, L., Scarlatti, G., Burastero, S., Tambussi, G., Colognesi, C., Quillent, C., Longhi, R., Loverro, P., Borgonovo, B., Gaffi, D., Carrow, E., Malnati, M., Lusso, P., Siccardi, A.G., Lazzarin, A., and Beretta, A.
- Subjects
Cytokines -- Physiological aspects ,HIV (Viruses) -- Inactivation ,Cell-mediated cytotoxicity -- Analysis ,T cells -- Physiological aspects - Abstract
Furci, L.; Scarlatti, G.; Burastero, S.; Tambussi, G.; Colognesi, C.; Quillent, C.; Longhi, R.; Loverro, P.; Borgonovo, B.; Gaffi, D.; Carrow, E.; Malnati, M.; Lusso, P.; Siccardi, A.G.; Lazzarin, A.; [...]
- Published
- 1997
77. Long-Term Preservation of Homologous Saphenous Veins for Vascular Access in Hemodialysis by Deep-Freezing
- Author
-
Baraldi, B., primary, Manenti, A., additional, Di Felice, A., additional, Leonelli, M., additional, Furci, L., additional, Grosoli, M., additional, Bonucchi, D., additional, and Lusvarghi, E., additional
- Published
- 1988
- Full Text
- View/download PDF
78. Absence of Rejection in Cryopreserved Saphenous Vein Allografts for Hemodialysis
- Author
-
BARALDI, A., primary, MANENTI, A., additional, FELICE, A. DI, additional, GROSOLI, M., additional, FURCI, L., additional, LEONELLI, M., additional, MANCA, V., additional, RONCACLIA, R., additional, and LUSVARGHI, E., additional
- Published
- 1989
- Full Text
- View/download PDF
79. CYCLOSPORIN A (CyA) INDUCED ENDOTHELIAL CELL INJURY
- Author
-
Zoja, C, additional, Furci, L, additional, Ghilardi, F, additional, Zilio, P, additional, Benigni, A, additional, and Remuzzi, G, additional
- Published
- 1987
- Full Text
- View/download PDF
80. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
- Author
-
Rivasi Paolo, Romano Nicola, Magistroni Riccardo, Leonelli Marco, Furci Luciana, Russi Gianpaolo, and Albertazzi Alberto
- Subjects
Medicine - Abstract
Abstract Introduction Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity. It is histologically characterized by a marked dilatation of the glomerular capillaries and the presence of lipoprotein thrombi in the glomerular lumens. The dyslipidemic profile is similar to that of type III dyslipoproteinemia with Apolipoprotein E values that are often high; proteinuria and renal dysfunction are present. Proteinuria often does not respond to steroid and cytostatic treatments. The phenotypic expression of lipoprotein glomerulopathy is most probably correlated to a genetic alteration of the lipoprotein metabolism (mutation of the Apolipoprotein E coding gene). In literature, lipoprotein glomerulopathies have mainly been reported in Japanese and Chinese subjects, except for three cases in the Caucasian race, reported in France and the USA. Case presentation We describe the case of a 60-year-old female, Caucasian patient suffering from lipoprotein glomerulopathy, carrier of a new mutation on the Apolipoprotein E gene (Apolipoprotein EMODENA), and treated successfully with low density lipoprotein-apheresis with the Heparin induced extracorporeal lipoprotein precipitation system. After a first phase of therapeutic protocol with statins, the patient was admitted for nephrotic syndrome, renal failure and hypertension. Since conventional treatment alone was not able to control dyslipidemia, aphaeretic treatment with heparin-induced Extracorporeal Lipoprotein Precipitation - apheresis (HELP-apheresis) was started to maintain angiotensin converting enzyme inhibitor therapy for the treatment of hypertension. Treatment with HELP-apheresis led to a complete remission of the proteinuria in a very short time (four months), as well as control of hypercholesterolemia and renal function recovery. Conclusion According to this case of lipoprotein glomerulopathy, we believe that renal damage expressed by proteinuria correlates to the levels of lipids and, furthermore, the treatment with HELP-apheresis, by lowering low-density lipoprotein cholesterol and triglycerides, may be considered as a therapeutic option in synergy with pharmacological treatment in the treatment of lipoprotein glomerulopathy.
- Published
- 2009
- Full Text
- View/download PDF
81. CYCLOSPORIN A (CyA) INDUCED ENDOTHELIAL CELL INJURY
- Author
-
Zoja, C, Furci, L, Ghilardi, F, Zilio, P, Benigni, A, and Remuzzi, G
- Published
- 1987
- Full Text
- View/download PDF
82. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
- Author
-
Sean J. Barbour, Rosanna Coppo, Hong Zhang, Zhi-Hong Liu, Yusuke Suzuki, Keiichi Matsuzaki, Lee Er, Heather N. Reich, Jonathan Barratt, Daniel C. Cattran, M.L. Russo, S. Troyanov, H.T. Cook, I. Roberts, V. Tesar, D. Maixnerova, S. Lundberg, L. Gesualdo, F. Emma, L. Fuiano, G. Beltrame, C. Rollino, A. Amore, R. Camilla, L. Peruzzi, M. Praga, S. Feriozzi, R. Polci, G. Segoloni, L. Colla, A. Pani, D. Piras, A. Angioi, G. Cancarini, S. Ravera, M. Durlik, E. Moggia, J. Ballarin, S. Di Giulio, F. Pugliese, I. Serriello, Y. Caliskan, M. Sever, I. Kilicaslan, F. Locatelli, L. Del Vecchio, J.F.M. Wetzels, H. Peters, U. Berg, F. Carvalho, A.C. da Costa Ferreira, M. Maggio, A. Wiecek, M. Ots-Rosenberg, R. Magistroni, R. Topaloglu, Y. Bilginer, M. D’Amico, M. Stangou, F. Giacchino, D. Goumenos, E. Papachristou, K. Galesic, C. Geddes, K. Siamopoulos, O. Balafa, M. Galliani, P. Stratta, M. Quaglia, R. Bergia, R. Cravero, M. Salvadori, L. Cirami, B. Fellstrom, H. Kloster Smerud, F. Ferrario, T. Stellato, J. Egido, C. Martin, J. Floege, F. Eitner, A. Lupo, P. Bernich, P. Menè, M. Morosetti, C. van Kooten, T. Rabelink, M.E.J. Reinders, J.M. Boria Grinyo, S. Cusinato, L. Benozzi, S. Savoldi, C. Licata, M. Mizerska-Wasiak, G. Martina, A. Messuerotti, A. Dal Canton, C. Esposito, C. Migotto, G. Triolo, F. Mariano, C. Pozzi, R. Boero, S. Bellur, G. Mazzucco, C. Giannakakis, E. Honsova, B. Sundelin, A.M. Di Palma, E. Gutiérrez, A.M. Asunis, J. Barratt, R. Tardanico, A. Perkowska-Ptasinska, J. Arce Terroba, M. Fortunato, A. Pantzaki, Y. Ozluk, E. Steenbergen, M. Soderberg, Z. Riispere, L. Furci, D. Orhan, D. Kipgen, D. Casartelli, D. Galesic Ljubanovic, H. Gakiopoulou, E. Bertoni, P. Cannata Ortiz, H. Karkoszka, H.J. Groene, A. Stoppacciaro, I. Bajema, J. Bruijn, X. Fulladosa Oliveras, J. Maldyk, E. Ioachim, N. Bavbek, T. Cook, C. Alpers, F. Berthoux, S. Bonsib, V. D’Agati, G. D’Amico, S. Emancipator, F. Emmal, F. Fervenza, S. Florquin, A. Fogo, H. Groene, M. Haas, P. Hill, R. Hogg, S. Hsu, T. Hunley, M. Hladunewich, C. Jennette, K. Joh, B. Julian, T. Kawamura, F. Lai, C. Leung, L. Li, P. Li, Z. Liu, A. Massat, B. Mackinnon, S. Mezzano, F. Schena, Y. Tomino, P. Walker, H. Wang, J. Weening, N. Yoshikawa, C.-H. Zeng, S. Shi, C. Nogi, H. Suzuki, K. Koike, K. Hirano, T. Yokoo, M. Hanai, K. Fukami, K. Takahashi, Y. Yuzawa, M. Niwa, Y. Yasuda, S. Maruyama, D. Ichikawa, T. Suzuki, S. Shirai, A. Fukuda, S. Fujimoto, H. Trimarchi, Triolo, G., Mariano, F., Pozzi, C., Boero, R., Bellur, S., Mazzucco, G., Giannakakis, C., Honsova, E., Sundelin, B., Di Palma, A. M., Russo, M. L., Ferrario, F., Gutiérrez, E., Asunis, A. M., Barratt, J., Tardanico, R., Perkowska-Ptasinska, A., Terroba, J. Arce, Fortunato, M., Pantzaki, A., Ozluk, Y., Troyanov, S., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., Ljubanovic, D. Galesic, Gakiopoulou, H., Bertoni, E., Cook, H. T., Cannata Ortiz, P., Karkoszka, H., Groene, H. J., Stoppacciaro, A., Bajema, I., Bruijn, J., Fulladosa Oliveras, X., Maldyk, J., Ioachim, E., Bavbek, N., Roberts, I., Cook, T., Alpers, C., Amore, A., Berthoux, F., Bonsib, S., D'Agati, V., D'Amico, G., Tesar, V., Emancipator, S., Emmal, F., Fervenza, F., Florquin, S., Fogo, A., Geddes, C., Groene, H., Haas, M., Hill, P., Maixnerova, D., Hogg, R., Hsu, S., Hunley, T., Hladunewich, M., Jennette, C., Joh, K., Julian, B., Kawamura, T., Lai, F., Leung, C., Lundberg, S., Li, L., Li, P., Liu, Z., Massat, A., Mackinnon, B., Mezzano, S., Schena, F., Tomino, Y., Walker, P., Wang, H., Gesualdo, L., Weening, J., Yoshikawa, N., Zeng, C.-H., Shi, S., Nogi, C., Suzuki, H., Koike, K., Hirano, K., Yokoo, T., Emma, F., Hanai, M., Fukami, K., Takahashi, K., Yuzawa, Y., Niwa, M., Yasuda, Y., Maruyama, S., Ichikawa, D., Suzuki, T., Shirai, S., Fuiano, L., Fukuda, A., Fujimoto, S., Trimarchi, H., Beltrame, G., Rollino, C., Camilla, R., Peruzzi, L., Praga, M., Feriozzi, S., Polci, R., Segoloni, G., Colla, L., Pani, A., Piras, D., Angioi, A., Cancarini, G., Ravera, S., Durlik, M., Moggia, E., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Caliskan, Y., Sever, M., Kilicaslan, I., Locatelli, F., Del Vecchio, L., Wetzels, J. F. M., Peters, H., Berg, U., Carvalho, F., da Costa Ferreira, A. C., Maggio, M., Wiecek, A., Ots-Rosenberg, M., Magistroni, R., Topaloglu, R., Bilginer, Y., D'Amico, M., Stangou, M., Giacchino, F., Goumenos, D., Papachristou, E., Galesic, K., Siamopoulos, K., Balafa, O., Galliani, M., Stratta, P., Quaglia, M., Bergia, R., Cravero, R., Salvadori, M., Cirami, L., Fellstrom, B., Smerud, H. Kloster, Stellato, T., Egido, J., Martin, C., Flöge, Jürgen, Eitner, F., Lupo, A., Bernich, P., Menè, P., Morosetti, M., van Kooten, C., Rabelink, T., Reinders, M. E. J., Boria Grinyo, J. M., Cusinato, S., Benozzi, L., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Martina, G., Messuerotti, A., Dal Canton, A., Esposito, C., Migotto, C., Pathology, Center of Experimental and Molecular Medicine, Graduate School, and ACS - Heart failure & arrhythmias
- Subjects
Adult ,disease progression ,end-stage kidney disease ,IgA nephropathy ,prediction tool ,risk prediction ,Biopsy ,Glomerulonephritis, IGA ,Prognosis ,Cohort Studies ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,Nephrology ,Humans ,Renal Insufficiency ,Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] ,Glomerular Filtration Rate - Abstract
Kidney international 102(1), 160-172 (2022). doi:10.1016/j.kint.2022.02.042, Published by Elsevier, New York, NY
- Published
- 2022
- Full Text
- View/download PDF
83. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy
- Author
-
Corrado Murtas, Pietro Ravani, Francesca Bruno, Maurizio Bruschi, Piergiorgio Messa, Riccardo Magistroni, Francesco Scolari, Giovanni Candiano, Landino Allegri, Andrea Magnano, Fernando C. Fervenza, Maria Luisa Carnevali, Gian Marco Ghiggeri, Lucia Argentiero, L. Furci, Renato Alberto Sinico, Antonella Radice, Gabriella Moroni, Loreto Gesualdo, Murtas, C, Bruschi, M, Candiano, G, Moroni, G, Magistroni, R, Magnano, A, Bruno, F, Radice, A, Furci, L, Argentiero, L, Carnevali, M, Messa, P, Scolari, F, Sinico, R, Gesualdo, L, Fervenza, F, Allegri, L, Ravani, P, and Ghiggeri, G
- Subjects
Male ,Registrie ,nefrologia ,Time Factors ,Epidemiology ,glomerulonefrite membranosa ,Critical Care and Intensive Care Medicine ,Glomerulonephritis, Membranous ,Immunoglobulin G ,Retrospective Studie ,Medicine ,Registries ,antigene ,Proteinuria ,biology ,Podocytes ,Glomerulosclerosis, Focal Segmental ,Middle Aged ,Glomerulonephritis, Membranou ,Isotype ,Autoantibodie ,sindrome nefrosica ,Italy ,Nephrology ,Linear Model ,Female ,Neprilysin ,medicine.symptom ,Human ,Adult ,Adolescent ,Logistic Model ,Time Factor ,Podocyte ,Nephropathy ,Young Adult ,Antigen ,Membranous nephropathy ,Aldehyde Reductase ,Humans ,Autoantibodies ,Retrospective Studies ,Aged ,Transplantation ,business.industry ,Superoxide Dismutase ,Receptors, Phospholipase A2 ,Autoantibody ,Glomerulonephritis, IGA ,Original Articles ,medicine.disease ,Logistic Models ,Phosphopyruvate Hydratase ,Immunology ,Linear Models ,biology.protein ,business - Abstract
Summary Background and objectives The discovery of different podocyte autoantibodies in membranous nephropathy (MN) raises questions about their pathogenetic and clinical meaning. This study sought to define antibody isotypes and correlations; to compare levels in MN, other glomerulonephritides, and controls; and to determine their association with clinical outcomes. Design, setting, participants, & measurements Serum IgG1 ,I gG3 ,a nd IgG4 against aldose reductase (AR), SOD2, and a-enolase (aENO) were measured at diagnosis in 186 consecutive MN patients, in 96 proteinuric controls (36 with FSGS, and 60 with IgA nephropathy), and in 92 healthy people recruited in four Italian nephrology units. Anti-phospholipase A2 receptor (PLA2r) and anti-neutral endopeptidase (NEP) IgG4 were titrated in the same specimens. Association with 1-year follow-up clinical parameters was studied in 120 patients. Results IgG4 was the most common isotype for all antibodies; IgG1 and IgG3 were nearly negligible. IgG4 levels werepositiveinasignificantproportionofMNpatients(AR,34%;SOD2,28%;aENO,43%).Antibodytiterswere higher in MN than in healthy and pathologic controls (P,0.005). Anti-NEP IgG4 did not differ from normal controls (P=0.12). Anti-PLA2r IgG4 was detected in 60% of patients and correlated with anti-AR, anti-SOD2, and anti-aENO IgG4 (P,0.001). In MN patients negative for the whole antibody panel (20%), 1-year proteinuria was lower compared with patients with at least one antibody positivity (P,0.05). Conclusions Our data suggest that IgG4 is the prevalent isotype for antibodies against cytoplasmic antigens of podocytes (AR, SOD2, aENO). Their levels were higher than in other proteinuric glomerulonephritides and in normal controls and were correlated with anti-PLA2r. Only baseline negativity for all known antibodies predicted lower 1-year proteinuria. Clin J Am Soc Nephrol 7: ccc–ccc, 2012. doi: 10.2215/CJN.02170312
- Published
- 2012
84. Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers
- Author
-
Riccardo Magistroni, Fabrizio Cavazzini, L. Furci, Alberto Albertazzi, Enzo Spisni, Giulia Ligabue, Filippo Genovese, Mario Masellis, Valentina Lupo, Marco Cantu, Magistroni R., Cantù M., Ligabue G., Masellis M., Spisni E., Furci L., Lupo V., Genovese F., Cavazzini F., and Albertazzi A.
- Subjects
Pathology ,medicine.medical_specialty ,1D and 2D gel electrophoresis ,interstitial fluid ,Biopsy ,SELDI-ToF ,Proteomics ,Kidney ,Interstitial fluid ,Predictive Value of Tests ,Medicine ,Humans ,Electrophoresis, Gel, Two-Dimensional ,biologic fluid ,Gel electrophoresis ,Two-dimensional gel electrophoresis ,renal biomarkers ,MALDI-TOF-MS ,medicine.diagnostic_test ,business.industry ,Diagnostic Tests, Routine ,Extracellular Fluid ,Prognosis ,Kidney Neoplasms ,Matrix-assisted laser desorption/ionization ,medicine.anatomical_structure ,Nephrology ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,PROTEOMICS ,SECRETOME ,Kidney Diseases ,Renal biopsy ,business ,Biomarkers - Abstract
Introduction: Development of renal biomarkers is required to improve on diagnostic accuracy, prognosis and prediction of response to therapy in renal disease. We describe a new method of obtaining from renal specimens a biologic fluid potentially enriched in secreted proteins. Methods: A renal biopsy specimen was centrifuged, and the interstitial fluid (IF) obtained was evaluated by SELDI-ToF, 1D and 2D gel electrophoresis. Twelve spots were extracted from the 2D gel and characterized by MALDI-TOF-MS. Results: The SELDI diagrams demonstrated abundant peptide peaks. One-dimensional gel electrophoresis demonstrated the presence of many bands indicating a diversity of proteins in the sample. Comparison of serum to IF demonstrated a number of bands that were not shared, suggesting that the IF is not a simple “replica” of plasma fluid. Employing 2D-PAGE, 418 spots were identified in the IF sample; 12 spots were selected and analyzed by mass spectrometry. Conclusions: We have described a novel technique to obtain a biologic fluid that contains a significant quantity and diversity of proteins from renal tissue. The procedure to obtain the fluid is simple and easily applicable to standard renal biopsy procedures. This fluid has the potential to identify informative proteins that are more concentrated than in any other renal biologic fluid previously analyzed and strictly related to renal pathophysiology. Future work includes the development of a clinical protocol to identify and validate informative biomarkers that have diagnostic and prognostic value.
- Published
- 2010
85. RNA N6-adenine methylation dynamics impact Hyaloperonospora arabidopsidis resistance in Arabidopsis.
- Author
-
Furci L, Berthelier J, and Saze H
- Subjects
- Methylation, Gene Expression Regulation, Plant, Adenine metabolism, Adenine analogs & derivatives, RNA, Plant genetics, Arabidopsis genetics, Arabidopsis microbiology, Disease Resistance genetics, Plant Diseases microbiology, Plant Diseases genetics, Oomycetes pathogenicity, Oomycetes physiology
- Abstract
In plants, epitranscriptomic mark N6-adenine methylation (m6A) is dynamically regulated in response to environmental cues. However, little is known about m6A dynamics under biotic stresses and their role in environmental adaptation. Additionally, current methodologies limit the investigation of m6A dynamics at single-nucleotide resolution on specific RNA molecules. Using Oxford Nanopore Technology direct RNA sequencing and a neural network model, we show transcript-specific dynamics of m6A modification at single-nucleotide resolution during Hyaloperonospora arabidopsidis (Hpa) infection in Arabidopsis (Arabidopsis thaliana). In wild-type seedlings, pathogen infection causes a significant reduction in global m6A ratios, which corresponds with the activation of m6A-modified transcripts. Defect of m6A deposition in the m6A mutant hakai-1 mimics m6A reduction from Hpa infection at ∼70% of sites, resulting in constitutive overexpression of basal defense genes and enhanced resistance against the pathogen. Our results demonstrate that m6A dynamics impact defense response against Hpa, providing a promising target for future crop improvement strategies., Competing Interests: Conflict of interest statement. None declared., (© The Author(s) 2024. Published by Oxford University Press on behalf of American Society of Plant Biologists.)
- Published
- 2024
- Full Text
- View/download PDF
86. Long-read direct RNA sequencing reveals epigenetic regulation of chimeric gene-transposon transcripts in Arabidopsis thaliana.
- Author
-
Berthelier J, Furci L, Asai S, Sadykova M, Shimazaki T, Shirasu K, and Saze H
- Subjects
- Epigenesis, Genetic, Gene Expression Regulation, Plant, DNA Transposable Elements genetics, RNA, Small Interfering genetics, RNA, Messenger genetics, Sequence Analysis, RNA, Arabidopsis genetics
- Abstract
Transposable elements (TEs) are accumulated in both intergenic and intragenic regions in plant genomes. Intragenic TEs often act as regulatory elements of associated genes and are also co-transcribed with genes, generating chimeric TE-gene transcripts. Despite the potential impact on mRNA regulation and gene function, the prevalence and transcriptional regulation of TE-gene transcripts are poorly understood. By long-read direct RNA sequencing and a dedicated bioinformatics pipeline, ParasiTE, we investigated the transcription and RNA processing of TE-gene transcripts in Arabidopsis thaliana. We identified a global production of TE-gene transcripts in thousands of A. thaliana gene loci, with TE sequences often being associated with alternative transcription start sites or transcription termination sites. The epigenetic state of intragenic TEs affects RNAPII elongation and usage of alternative poly(A) signals within TE sequences, regulating alternative TE-gene isoform production. Co-transcription and inclusion of TE-derived sequences into gene transcripts impact regulation of RNA stability and environmental responses of some loci. Our study provides insights into TE-gene interactions that contributes to mRNA regulation, transcriptome diversity, and environmental responses in plants., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
87. A rapid and non-destructive method for spatial-temporal quantification of colonization by Pseudomonas syringae pv. tomato DC3000 in Arabidopsis and tomato.
- Author
-
Furci L, Pascual-Pardo D, and Ton J
- Abstract
Background: The bacterial leaf pathogen Pseudomonas syringae pv tomato (Pst) is the most popular model pathogen for plant pathology research. Previous methods to study the plant-Pst interactions rely on destructive quantification of Pst colonisation, which can be labour- and time-consuming and does not allow for spatial-temporal monitoring of the bacterial colonisation. Here, we describe a rapid and non-destructive method to quantify and visualise spatial-temporal colonisation by Pst in intact leaves of Arabidopsis and tomato., Results: The method presented here uses a bioluminescent Pst DC3000 strain that constitutively expresses the luxCDABE operon from Photorhabdus luminescens (Pst::LUX) and requires a common gel documentation (Gel Doc) system with a sensitive CCD/CMOS camera and imaging software (Photoshop or Image J). By capturing bright field and bioluminescence images from Pst::LUX-infected leaves, we imaged the spatiotemporal dynamics of Pst infection. Analysis of bioluminescence from live Pst bacteria over a 5-day time course after spray inoculation of Arabidopsis revealed transition of the bacterial presence from the older leaves to the younger leaves and apical meristem. Colonisation by Pst:LUX bioluminescence was obtained from digital photos by calculating relative bioluminescence values, which is adjusted for bioluminescence intensity and normalised by leaf surface. This method detected statistically significant differences in Pst::LUX colonisation between Arabidopsis genotypes varying in basal resistance, as well as statistically significant reductions in Pst::LUX colonisation by resistance-inducing treatments in both Arabidopsis and tomato. Comparison of relative bioluminescence values to conventional colony counting on selective agar medium revealed a statistically significant correlation, which was reproducible between different Gel Doc systems., Conclusions: We present a non-destructive method to quantify colonisation by bioluminescent Pst::LUX in plants. Using a common Gel Doc system and imaging software, our method requires less time and labour than conventional methods that are based on destructive sampling of infected leaf material. Furthermore, in contrast to conventional strategies, our method provides additional information about the spatial-temporal patterns of Pst colonisation., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
88. Costs and Benefits of Transgenerational Induced Resistance in Arabidopsis.
- Author
-
López Sánchez A, Pascual-Pardo D, Furci L, Roberts MR, and Ton J
- Abstract
Recent evidence suggests that stressed plants employ epigenetic mechanisms to transmit acquired resistance traits to their progeny. However, the evolutionary and ecological significance of transgenerational induced resistance (t-IR) is poorly understood because a clear understanding of how parents interpret environmental cues in relation to the effectiveness, stability, and anticipated ecological costs of t-IR is lacking. Here, we have used a full factorial design to study the specificity, costs, and transgenerational stability of t-IR following exposure of Arabidopsis thaliana to increasing stress intensities by a biotrophic pathogen, a necrotrophic pathogen, and salinity. We show that t-IR in response to infection by biotrophic or necrotrophic pathogens is effective against pathogens of the same lifestyle. This pathogen-mediated t-IR is associated with ecological costs, since progeny from biotroph-infected parents were more susceptible to both necrotrophic pathogens and salt stress, whereas progeny from necrotroph-infected parents were more susceptible to biotrophic pathogens. Hence, pathogen-mediated t-IR provides benefits when parents and progeny are in matched environments but is associated with costs that become apparent in mismatched environments. By contrast, soil salinity failed to mediate t-IR against salt stress in matched environments but caused non-specific t-IR against both biotrophic and necrotrophic pathogens in mismatched environments. However, the ecological relevance of this non-specific t-IR response remains questionable as its induction was offset by major reproductive costs arising from dramatically reduced seed production and viability. Finally, we show that the costs and transgenerational stability of pathogen-mediated t-IR are proportional to disease pressure experienced by the parents, suggesting that plants use disease severity as an environmental proxy to adjust investment in t-IR., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 López Sánchez, Pascual-Pardo, Furci, Roberts and Ton.)
- Published
- 2021
- Full Text
- View/download PDF
89. Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks.
- Author
-
Ligabue G, Pollastri F, Fontana F, Leonelli M, Furci L, Giovanella S, Alfano G, Cappelli G, Testa F, Bolelli F, Grana C, and Magistroni R
- Subjects
- Adult, Aged, Area Under Curve, Biopsy, Complement C1q metabolism, Complement C3 metabolism, Female, Fibrinogen metabolism, Fluorescent Antibody Technique, Direct, Humans, Image Processing, Computer-Assisted methods, Immunoglobulin kappa-Chains metabolism, Immunoglobulin lambda-Chains metabolism, Kidney Diseases diagnosis, Male, Middle Aged, ROC Curve, Immunoglobulins metabolism, Kidney metabolism, Kidney pathology, Kidney Diseases metabolism, Kidney Diseases pathology, Neural Networks, Computer
- Abstract
Background and Objectives: Immunohistopathology is an essential technique in the diagnostic workflow of a kidney biopsy. Deep learning is an effective tool in the elaboration of medical imaging. We wanted to evaluate the role of a convolutional neural network as a support tool for kidney immunofluorescence reporting., Design, Setting, Participants, & Measurements: High-magnification (×400) immunofluorescence images of kidney biopsies performed from the year 2001 to 2018 were collected. The report, adopted at the Division of Nephrology of the AOU Policlinico di Modena, describes the specimen in terms of "appearance," "distribution," "location," and "intensity" of the glomerular deposits identified with fluorescent antibodies against IgG, IgA, IgM, C1q and C3 complement fractions, fibrinogen, and κ - and λ -light chains. The report was used as ground truth for the training of the convolutional neural networks., Results: In total, 12,259 immunofluorescence images of 2542 subjects undergoing kidney biopsy were collected. The test set analysis showed accuracy values between 0.79 ("irregular capillary wall" feature) and 0.94 ("fine granular" feature). The agreement test of the results obtained by the convolutional neural networks with respect to the ground truth showed similar values to three pathologists of our center. Convolutional neural networks were 117 times faster than human evaluators in analyzing 180 test images. A web platform, where it is possible to upload digitized images of immunofluorescence specimens, is available to evaluate the potential of our approach., Conclusions: The data showed that the accuracy of convolutional neural networks is comparable with that of pathologists experienced in the field., (Copyright © 2020 by the American Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
90. Erratum.
- Author
-
Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Maria Asunis A, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Haider SA, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, and Tardanico R
- Published
- 2020
- Full Text
- View/download PDF
91. Transcriptional regulation of genes bearing intronic heterochromatin in the rice genome.
- Author
-
Espinas NA, Tu LN, Furci L, Shimajiri Y, Harukawa Y, Miura S, Takuno S, and Saze H
- Subjects
- Chromatin genetics, DNA Methylation genetics, DNA Transposable Elements genetics, Epigenesis, Genetic genetics, Gene Expression Regulation genetics, Promoter Regions, Genetic genetics, Genome, Plant genetics, Heterochromatin genetics, Introns genetics, Oryza genetics, Transcription, Genetic genetics
- Abstract
Intronic regions of eukaryotic genomes accumulate many Transposable Elements (TEs). Intronic TEs often trigger the formation of transcriptionally repressive heterochromatin, even within transcription-permissive chromatin environments. Although TE-bearing introns are widely observed in eukaryotic genomes, their epigenetic states, impacts on gene regulation and function, and their contributions to genetic diversity and evolution, remain poorly understood. In this study, we investigated the genome-wide distribution of intronic TEs and their epigenetic states in the Oryza sativa genome, where TEs comprise 35% of the genome. We found that over 10% of rice genes contain intronic heterochromatin, most of which are associated with TEs and repetitive sequences. These heterochromatic introns are longer and highly enriched in promoter-proximal positions. On the other hand, introns also accumulate hypomethylated short TEs. Genes with heterochromatic introns are implicated in various biological functions. Transcription of genes bearing intronic heterochromatin is regulated by an epigenetic mechanism involving the conserved factor OsIBM2, mutation of which results in severe developmental and reproductive defects. Furthermore, we found that heterochromatic introns evolve rapidly compared to non-heterochromatic introns. Our study demonstrates that heterochromatin is a common epigenetic feature associated with actively transcribed genes in the rice genome., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
92. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
- Author
-
Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Asunis AM, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Asma Haider S, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, and Tardanico R
- Subjects
- Biopsy, Glomerular Filtration Rate, Glomerulonephritis, IGA drug therapy, Humans, Immunosuppressive Agents therapeutic use, Prognosis, Reproducibility of Results, Retrospective Studies, Glomerulonephritis, IGA classification, Glomerulonephritis, IGA pathology, Models, Statistical, Observer Variation, Patient Selection
- Abstract
Background: The VALidation of IGA (VALIGA) study investigated the utility of the Oxford Classification of immunoglobulin A nephropathy (IgAN) in 1147 patients from 13 European countries. Methods. Biopsies were scored by local pathologists followed by central review in Oxford. We had two distinct objectives: to assess how closely pathology findings were associated with the decision to give corticosteroid/immunosuppressive (CS/IS) treatments, and to determine the impact of differences in MEST-C scoring between central and local pathologists on the clinical value of the Oxford Classification. We tested for each lesion the associations between the type of agreement (local and central pathologists scoring absent, local present and central absent, local absent and central present, both scoring present) with the initial clinical assessment, as well as long-term outcomes in those patients who did not receive CS/IS., Results: All glomerular lesions (M, E, C and S) assessed by local pathologists were independently associated with the decision to administer CS/IS therapy, while the severity of tubulointerstitial lesions was not. Reproducibility between local and central pathologists was moderate for S (segmental sclerosis) and T (tubular atrophy/interstitial fibrosis), and poor for M (mesangial hypercellularity), E (endocapillary hypercellularity) and C (crescents). Local pathologists found statistically more of each lesion, except for the S lesion, which was more frequent with central review. Disagreements were more likely to occur when the proportion of glomeruli affected was low. The M lesion, assessed by central pathologists, correlated better with the severity of the disease at presentation and discriminated better with outcomes. In contrast, the E lesion, evaluated by local pathologists, correlated better with the clinical presentation and outcomes when compared with central review. Both C and S lesions, when discordant between local and central pathologists, had a clinical phenotype intermediate to double absent lesions (milder disease) and double present (more severe)., Conclusion: We conclude that differences in the scoring of MEST-C criteria between local pathologists and a central reviewer have a significant impact on the prognostic value of the Oxford Classification. Since the decision to offer immunosuppressive therapy in this cohort was intimately associated with the MEST-C score, this study indicates a need for a more detailed guidance for pathologists in the scoring of IgAN biopsies., (© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
93. Surviving in a Hostile World: Plant Strategies to Resist Pests and Diseases.
- Author
-
Wilkinson SW, Magerøy MH, López Sánchez A, Smith LM, Furci L, Cotton TEA, Krokene P, and Ton J
- Subjects
- Adaptation, Physiological, Biological Evolution, Plant Diseases, Herbivory, Plants
- Abstract
As primary producers, plants are under constant pressure to defend themselves against potentially deadly pathogens and herbivores. In this review, we describe short- and long-term strategies that enable plants to cope with these stresses. Apart from internal immunological strategies that involve physiological and (epi)genetic modifications at the cellular level, plants also employ external strategies that rely on recruitment of beneficial organisms. We discuss these strategies along a gradient of increasing timescales, ranging from rapid immune responses that are initiated within seconds to (epi)genetic adaptations that occur over multiple plant generations. We cover the latest insights into the mechanistic and evolutionary underpinnings of these strategies and present explanatory models. Finally, we discuss how knowledge from short-lived model species can be translated to economically and ecologically important perennials to exploit adaptive plant strategies and mitigate future impacts of pests and diseases in an increasingly interconnected and changing world.
- Published
- 2019
- Full Text
- View/download PDF
94. Identification and characterisation of hypomethylated DNA loci controlling quantitative resistance in Arabidopsis .
- Author
-
Furci L, Jain R, Stassen J, Berkowitz O, Whelan J, Roquis D, Baillet V, Colot V, Johannes F, and Ton J
- Subjects
- Centromere ultrastructure, Cluster Analysis, Epigenesis, Genetic, Epigenomics, Gene Expression Profiling, Gene Expression Regulation, Plant, Genes, Plant, Haplotypes, Oomycetes pathogenicity, Phenotype, Plant Diseases microbiology, Quantitative Trait Loci, Quantitative Trait, Heritable, Sequence Analysis, RNA, Arabidopsis genetics, DNA Methylation, DNA, Plant chemistry, Disease Resistance genetics, Plant Diseases genetics
- Abstract
Variation in DNA methylation enables plants to inherit traits independently of changes to DNA sequence. Here, we have screened an Arabidopsis population of epigenetic recombinant inbred lines (epiRILs) for resistance against Hyaloperonospora arabidopsidis (Hpa) . These lines share the same genetic background, but show variation in heritable patterns of DNA methylation. We identified four epigenetic quantitative trait loci (epiQTLs) that provide quantitative resistance without reducing plant growth or resistance to other (a)biotic stresses. Phenotypic characterisation and RNA-sequencing analysis revealed that Hpa- resistant epiRILs are primed to activate defence responses at the relatively early stages of infection. Collectively, our results show that hypomethylation at selected pericentromeric regions is sufficient to provide quantitative disease resistance, which is associated with genome-wide priming of defence-related genes. Based on comparisons of global gene expression and DNA methylation between the wild-type and resistant epiRILs, we discuss mechanisms by which the pericentromeric epiQTLs could regulate the defence-related transcriptome., Competing Interests: LF, RJ, JS, OB, JW, DR, VB, VC, FJ, JT No competing interests declared, (© 2019, Furci et al.)
- Published
- 2019
- Full Text
- View/download PDF
95. The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition.
- Author
-
Solazzo A, Testa F, Giovanella S, Busutti M, Furci L, Carrera P, Ferrari M, Ligabue G, Mori G, Leonelli M, Cappelli G, and Magistroni R
- Subjects
- Aged, Cohort Studies, Europe epidemiology, Female, Humans, Male, Middle Aged, Polycystic Kidney, Autosomal Dominant diagnosis, Prevalence, Polycystic Kidney, Autosomal Dominant epidemiology
- Abstract
Background and Objectives: ADPKD is erroneously perceived as a not rare condition, which is mainly due to the repeated citation of a mistaken interpretation of old epidemiological data, as reported in the Dalgaard's work (1957). Even if ADPKD is not a common condition, the correct prevalence of ADPKD in the general population is uncertain, with a wide range of estimations reported by different authors. In this work, we have performed a meta-analysis of available epidemiological data in the European literature. Furthermore we collected the diagnosis and clinical data of ADPKD in a province in the north of Italy (Modena). We describe the point and predicted prevalence of ADPKD, as well as the main clinical characteristics of ADPKD in this region., Methods: We looked at the epidemiological data according to specific parameters and criteria in the Pubmed, CINAHL, Scopus and Web of Science databases. Data were summarized using linear regression analysis. We collected patients' diagnoses in the Province of Modena according to accepted clinical criteria and/or molecular analysis. Predicted prevalence has been calculated through a logistic regression prediction applied to the at-risk population., Results: The average prevalence of ADPKD, as obtained from 8 epidemiological studies of sufficient quality, is 2.7: 10,000 (CI95 = 0.73-4.67). The point prevalence of ADPKD in the province of Modena is 3.63: 10,000 (CI95 = 3.010-3.758). On the basis of the collected pedigrees and identification of the at-risk subjects, the predicted prevalence in the Province of Modena is 4.76: 10,000 (CI 95% = 4.109-4.918)., Conclusion: As identified in our study, point prevalence is comparable with the majority of the studies of literature, while predicted prevalence (4.76: 10,000) generally appears higher than in the previous estimates of the literature, with a few exceptions. Thus, this could suggest that undiagnosed ADPKD subjects, as predicted by our approach, could be relevant and will most likely require more clinical attention. Nevertheless, our estimation, in addition to the averaged ones derived from literature, not exceeding the limit of 5:10,000 inhabitants, are compatible with the definition of rare disease adopted by the European Medicines Agency and Food and Drug Administration.
- Published
- 2018
- Full Text
- View/download PDF
96. New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains.
- Author
-
Furci L, Baldan R, Bianchini V, Trovato A, Ossi C, Cichero P, and Cirillo DM
- Subjects
- Cell Membrane drug effects, Clostridioides difficile genetics, Clostridioides difficile isolation & purification, Clostridioides difficile ultrastructure, Enterococcus faecalis drug effects, Enterococcus faecalis ultrastructure, Enterocolitis, Pseudomembranous microbiology, Escherichia coli drug effects, Escherichia coli ultrastructure, Humans, Membrane Potentials drug effects, Microbial Sensitivity Tests, Microbial Viability drug effects, Ribotyping, Anti-Bacterial Agents pharmacology, Clostridioides difficile drug effects, alpha-Defensins pharmacology
- Abstract
Clostridium difficile infection (CDI), one of the most common hospital-acquired infections, is increasing in incidence and severity with the emergence and diffusion of hypervirulent strains. CDI is precipitated by antibiotic treatment that destroys the equilibrium of the gut microbiota. Human α-defensin 5 (HD5), the most abundant enteric antimicrobial peptide, is a key regulator of gut microbiota homeostasis, yet it is still unknown if C. difficile, which successfully evades killing by other host microbicidal peptides, is susceptible to HD5. We evaluated, by means of viability assay, fluorescence-activated cell sorter (FACS) analysis, and electron microscopy, the antimicrobial activities of α-defensins 1 and 5 against a panel of C. difficile strains encompassing the most prevalent epidemic and hypervirulent PCR ribotypes in Europe (012, 014/020, 106, 018, 027, and 078). Here we show that (i) concentrations of HD5 within the intestinal physiological range produced massive C. difficile cell killing; (ii) HD5 bactericidal activity was mediated by membrane depolarization and bacterial fragmentation with a pattern of damage peculiar to C. difficile bacilli, compared to commensals like Escherichia coli and Enterococcus faecalis; and (iii) unexpectedly, hypervirulent ribotypes were among the most susceptible to both defensins. These results support the notion that HD5, naturally present at very high concentrations in the mucosa of the small intestine, could indeed control the very early steps of CDI by killing C. difficile bacilli at their germination site. As a consequence, HD5 can be regarded as a good candidate for the containment of hypervirulent C. difficile strains, and it could be exploited in the therapy of CDI and relapsing C. difficile-associated disease., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
97. Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e.
- Author
-
Magistroni R, Bertolotti M, Furci L, Fano RA, Leonelli M, Pisciotta L, Pellegrini E, Calabresi L, Bertolini S, and Calandra S
- Abstract
Lipoprotein glomerulopathy is a pathological condition characterized by lipid accumulation in the glomerular capillaries that has been associated with the presence of rare mutants of apolipoprotein E (ApoE). We describe a 51-year-old Italian patient presenting Type III hyperlipidemia and proteinuria in whom renal biopsy showed capillary ectasia and intraluminal lipid deposits, suggesting the diagnosis of lipoprotein glomerulopathy. The patient, who had elevated plasma ApoE level, was found to be heterozygous for a mutation in ApoE (Arg150Cys), designated apoEMODENA. This mutation induces the formation of ApoE dimers that are detectable under non-reducing conditions. Treatment with hypolipidemic drugs did not result in a complete remission of the proteinuria and was accompanied by a slow but progressive worsening of renal function with the persistence of intracapillary lipid thrombi. The introduction of low-density lipoprotein aphaeresis combined with a more aggressive lipid lowering and antihypertensive therapy resulted in the remission of proteinuria and a substantial improvement of renal function. Switching from low-density lipoprotein aphaeresis to plasma filtration did not result in an equivalent control of renal damage. The patient died of intracranial hemorrhage during an acute episode of malignant hypertension.
- Published
- 2013
- Full Text
- View/download PDF
98. Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosis.
- Author
-
Furci L, Schena E, Miotto P, and Cirillo DM
- Abstract
Background: Mycobacterium tuberculosis (Mtb) has evolved multiple mechanisms to manipulate its cellular niche for its own advantage. Many efforts have been made to understand basal mechanisms of mycobacterial infections. However, the underlying molecular regulation is not fully understood. Recently, a new class of non-coding, small RNAs, called microRNAs (miRNAs), has emerged as important regulators in biological processes, and their involvement in mycobacterial infection has been identified, thus opening a new field of research., Methods: This study aimed to determine by TaqMan Low Density Array the host genome-wide miRNA expression profile of primary human monocyte-derived macrophages (MDM) infected with two members of the Mtb complex: virulent Mtb H37Rv and the non-virulent vaccine strain Mycobacterium bovis Bacillus Calmette-Guerin (BCG) in comparison with chemically-inactivated Mtb bacilli., Results: The findings of this study showed that infection of MDM with H37Rv or BCG results in a signature of miRNA expression mostly overlapping between the two mycobacteria. A substantially different signature emerged from infection with killed virulent bacilli, suggesting an active influence of live intracellular bacteria on cellular miRNA metabolism. Specifically, Mtb induced miRNA signature is composed of miRNAs well established in immune regulation, miR-155 and miR-146a, as well as a set of miRNAs newly associated with Mtb infection: miR-145, miR-222(∗), miR-27a and miR-27b. All of these miRNAs are predicted to target important immune-related genes., Conclusions: This study signifies the miRNA host response upon intracellular mycobacterial infection in macrophages, providing new aspects of regulation in host-pathogen interactions, at post-transcriptional levels., (Copyright © 2013. Published by Elsevier Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
99. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
- Author
-
Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, Bruno F, Radice A, Furci L, Argentiero L, Carnevali ML, Messa P, Scolari F, Sinico RA, Gesualdo L, Fervenza FC, Allegri L, Ravani P, and Ghiggeri GM
- Subjects
- Adolescent, Adult, Aged, Aldehyde Reductase immunology, Female, Glomerulonephritis, IGA immunology, Glomerulonephritis, Membranous blood, Glomerulonephritis, Membranous complications, Glomerulonephritis, Membranous enzymology, Glomerulosclerosis, Focal Segmental immunology, Humans, Italy, Linear Models, Logistic Models, Male, Middle Aged, Neprilysin immunology, Phosphopyruvate Hydratase immunology, Podocytes enzymology, Proteinuria immunology, Receptors, Phospholipase A2 immunology, Registries, Retrospective Studies, Superoxide Dismutase immunology, Time Factors, Young Adult, Autoantibodies blood, Glomerulonephritis, Membranous immunology, Immunoglobulin G blood, Podocytes immunology
- Abstract
Background and Objectives: The discovery of different podocyte autoantibodies in membranous nephropathy (MN) raises questions about their pathogenetic and clinical meaning. This study sought to define antibody isotypes and correlations; to compare levels in MN, other glomerulonephritides, and controls; and to determine their association with clinical outcomes., Design, Setting, Participants, & Measurements: Serum IgG(1), IgG(3), and IgG(4) against aldose reductase (AR), SOD2, and α-enolase (αENO) were measured at diagnosis in 186 consecutive MN patients, in 96 proteinuric controls (36 with FSGS, and 60 with IgA nephropathy), and in 92 healthy people recruited in four Italian nephrology units. Anti-phospholipase A2 receptor (PLA2r) and anti-neutral endopeptidase (NEP) IgG(4) were titrated in the same specimens. Association with 1-year follow-up clinical parameters was studied in 120 patients., Results: IgG(4) was the most common isotype for all antibodies; IgG(1) and IgG(3) were nearly negligible. IgG(4) levels were positive in a significant proportion of MN patients (AR, 34%; SOD2, 28%; αENO, 43%). Antibody titers were higher in MN than in healthy and pathologic controls (P<0.005). Anti-NEP IgG(4) did not differ from normal controls (P=0.12). Anti-PLA2r IgG(4) was detected in 60% of patients and correlated with anti-AR, anti-SOD2, and anti-αENO IgG(4) (P<0.001). In MN patients negative for the whole antibody panel (20%), 1-year proteinuria was lower compared with patients with at least one antibody positivity (P<0.05)., Conclusions: Our data suggest that IgG(4) is the prevalent isotype for antibodies against cytoplasmic antigens of podocytes (AR, SOD2, αENO). Their levels were higher than in other proteinuric glomerulonephritides and in normal controls and were correlated with anti-PLA2r. Only baseline negativity for all known antibodies predicted lower 1-year proteinuria.
- Published
- 2012
- Full Text
- View/download PDF
100. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor.
- Author
-
Auerbach DJ, Lin Y, Miao H, Cimbro R, Difiore MJ, Gianolini ME, Furci L, Biswas P, Fauci AS, and Lusso P
- Subjects
- Cells, Cultured, Humans, Membrane Fusion physiology, Platelet Factor 4 metabolism, Virus Replication, Blood Platelets metabolism, HIV-1 physiology, Platelet Factor 4 physiology
- Abstract
The natural history of HIV-1 infection is highly variable in different individuals, spanning from a rapidly progressive course to a long-term asymptomatic infection. A major determinant of the pace of disease progression is the in vivo level of HIV-1 replication, which is regulated by a complex network of cytokines and chemokines expressed by immune and inflammatory cells. The chemokine system is critically involved in the control of HIV-1 replication by virtue of the role played by specific chemokine receptors, most notably CCR5 and CXCR4, as cell-surface coreceptors for HIV-1 entry; hence, the chemokines that naturally bind such coreceptors act as endogenous inhibitors of HIV-1. Here, we show that the CXC chemokine CXCL4 (PF-4), the most abundant protein contained within the α-granules of platelets, is a broad-spectrum inhibitor of HIV-1 infection. Unlike other known HIV-suppressive chemokines, CXCL4 inhibits infection by the majority of primary HIV-1 isolates regardless of their coreceptor-usage phenotype or genetic subtype. Consistent with the lack of viral phenotype specificity, blockade of HIV-1 infection occurs at the level of virus attachment and entry via a unique mechanism that involves direct interaction of CXCL4 with the major viral envelope glycoprotein, gp120. The binding site for CXCL4 was mapped to a region of the gp120 outer domain proximal to the CD4-binding site. The identification of a platelet-derived chemokine as an endogenous antiviral factor may have relevance for the pathogenesis and treatment of HIV-1 infection.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.